Mogamulizumab for post-transplant relapse of adult T-cell leukemia/lymphoma: a case study

Mogamulizumab (MOG), a humanized monoclonal anti-CCR4 antibody, exerts strong antibody-dependent cellular cytotoxic effects on CCR4-positive adult T-cell leukemia/lymphoma (ATLL) cells. As CCR4 is highly expressed on regulatory T cells as well as ATLL cells, pre-transplant MOG induces severe graft-v...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirosawa, Makoto, Goto, Midori, Oku, Masahiko, Akao, Kenichi, Kitamura, Noriaki, Nakanishi, Tsukasa, Tanaka, Aya, Niino, Daisuke, Higashi, Takehiro, Morimoto, Hiroaki, Tsukada, Junichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813186/
https://www.ncbi.nlm.nih.gov/pubmed/36083572
http://dx.doi.org/10.1007/s12185-022-03447-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813186/
https://www.ncbi.nlm.nih.gov/pubmed/36083572
http://dx.doi.org/10.1007/s12185-022-03447-0

Ejemplares similares